240 related articles for article (PubMed ID: 15501770)
1. Novel human in vitro system for evaluating antimycobacterial vaccines.
Kampmann B; Tena GN; Mzazi S; Eley B; Young DB; Levin M
Infect Immun; 2004 Nov; 72(11):6401-7. PubMed ID: 15501770
[TBL] [Abstract][Full Text] [Related]
2. [Novel vaccines against M. tuberculosis].
Okada M
Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
[TBL] [Abstract][Full Text] [Related]
3. The immune response to BCG vaccination of newborns.
Hanekom WA
Ann N Y Acad Sci; 2005 Dec; 1062():69-78. PubMed ID: 16461790
[TBL] [Abstract][Full Text] [Related]
4. Broad heparin-binding haemagglutinin-specific cytokine and chemokine response in infants following Mycobacterium bovis BCG vaccination.
Smith SG; Lecher S; Blitz R; Locht C; Dockrell HM
Eur J Immunol; 2012 Sep; 42(9):2511-22. PubMed ID: 22653733
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of bacillus Calmette-Guérin vaccination of newborns and infants in the prevention of tuberculosis: meta-analyses of the published literature.
Colditz GA; Berkey CS; Mosteller F; Brewer TF; Wilson ME; Burdick E; Fineberg HV
Pediatrics; 1995 Jul; 96(1 Pt 1):29-35. PubMed ID: 7596718
[TBL] [Abstract][Full Text] [Related]
6. Protection against bovine tuberculosis induced by oral vaccination of cattle with Mycobacterium bovis BCG is not enhanced by co-administration of mycobacterial protein vaccines.
Wedlock DN; Aldwell FE; Vordermeier HM; Hewinson RG; Buddle BM
Vet Immunol Immunopathol; 2011 Dec; 144(3-4):220-7. PubMed ID: 22005585
[TBL] [Abstract][Full Text] [Related]
7. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
van Dissel JT; Soonawala D; Joosten SA; Prins C; Arend SM; Bang P; Tingskov PN; Lingnau K; Nouta J; Hoff ST; Rosenkrands I; Kromann I; Ottenhoff TH; Doherty TM; Andersen P
Vaccine; 2011 Mar; 29(11):2100-9. PubMed ID: 21256189
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of Mycobacterium tuberculosis antigens in Mycobacterium bovis BCG-vaccinated and M. bovis-infected cattle.
Mustafa AS; Skeiky YA; Al-Attiyah R; Alderson MR; Hewinson RG; Vordermeier HM
Infect Immun; 2006 Aug; 74(8):4566-72. PubMed ID: 16861643
[TBL] [Abstract][Full Text] [Related]
9. The cytokine response to bacille Calmette Guérin vaccination in South India.
Das SD; Narayanan PR; Kolappan C; Colston MJ
Int J Tuberc Lung Dis; 1998 Oct; 2(10):836-43. PubMed ID: 9783532
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of live tuberculosis vaccines after presensitization with Mycobacterium avium.
de Lisle GW; Wards BJ; Buddle BM; Collins DM
Tuberculosis (Edinb); 2005; 85(1-2):73-9. PubMed ID: 15687030
[TBL] [Abstract][Full Text] [Related]
11. Vaccination of neonatal calves with Mycobacterium bovis BCG induces protection against intranasal challenge with virulent M. bovis.
Hope JC; Thom ML; Villarreal-Ramos B; Vordermeier HM; Hewinson RG; Howard CJ
Clin Exp Immunol; 2005 Jan; 139(1):48-56. PubMed ID: 15606613
[TBL] [Abstract][Full Text] [Related]
12. Poor immunogenicity of BCG in helminth infected population is associated with increased in vitro TGF-beta production.
Elias D; Britton S; Aseffa A; Engers H; Akuffo H
Vaccine; 2008 Jul; 26(31):3897-902. PubMed ID: 18554755
[TBL] [Abstract][Full Text] [Related]
13. Vaccination of cattle against Mycobacterium bovis.
Buddle BM
Tuberculosis (Edinb); 2001; 81(1-2):125-32. PubMed ID: 11463233
[TBL] [Abstract][Full Text] [Related]
14. Consequence of prior exposure to environmental mycobacteria on BCG vaccination and diagnosis of tuberculosis infection.
Thom M; Howard C; Villarreal-Ramos B; Mead E; Vordermeier M; Hope J
Tuberculosis (Edinb); 2008 Jul; 88(4):324-34. PubMed ID: 18329343
[TBL] [Abstract][Full Text] [Related]
15. Neonatal bacillus Calmette-Guerin vaccination and environmental mycobacteria in sensitizing antimycobacterial activity of macrophages.
Periasamy M; Datta M; Kannapiran M; Ramanathan VD; Venkatesan P
Am J Med Sci; 2014 Jul; 348(1):57-64. PubMed ID: 24374737
[TBL] [Abstract][Full Text] [Related]
16. Cattle as a model for development of vaccines against human tuberculosis.
Buddle BM; Skinner MA; Wedlock DN; de Lisle GW; Vordermeier HM; Glyn Hewinson R
Tuberculosis (Edinb); 2005; 85(1-2):19-24. PubMed ID: 15687023
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma Low producer genotype +874 overrepresented in Bacillus Calmette-Guerin nonresponding children.
Anuradha B; Rakh SS; Ishaq M; Murthy KJ; Valluri VL
Pediatr Infect Dis J; 2008 Apr; 27(4):325-9. PubMed ID: 18379373
[TBL] [Abstract][Full Text] [Related]
18. [Frontier of mycobacterium research--host vs. mycobacterium].
Okada M; Shirakawa T
Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
[TBL] [Abstract][Full Text] [Related]
19. Environmental strains of Mycobacterium avium interfere with immune responses associated with Mycobacterium bovis BCG vaccination.
Young SL; Slobbe L; Wilson R; Buddle BM; de Lisle GW; Buchan GS
Infect Immun; 2007 Jun; 75(6):2833-40. PubMed ID: 17371857
[TBL] [Abstract][Full Text] [Related]
20. Tuberculosis: vaccines in the pipeline.
Ly LH; McMurray DN
Expert Rev Vaccines; 2008 Jul; 7(5):635-50. PubMed ID: 18564018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
